Synchronous biventricular pacing is a new nonpharmacological supplemental t
reatment of advanced heart failure associated with electromechanical conduc
tion delay. However, the role of pacing on left ventricular remodeling is u
nknown. Eleven patients with New York Heart Association Class III to IV hea
rt failure, a left ventricular ejection fraction < 35%, and a QRS duration
<greater than or equal to> 140 ms received a biventricular dual chamber pac
emaker. Serial echocardiography, g-minute hall walk, and Minnesota Living w
ith Heart Failure quality-of-life (QOL) questionnaire were performed before
and after up to 3 months of pacing. At 3 months there was a significant in
crease in fractional shortening (P < 0.001), ejection fraction (P < 0.001),
and cardiac output (P < 0.05). The left ventricular end-diastolic volume (
245 +/- 70 vs 185 +/- 37 mL, P < 0.05), end-systolic volume (209 +/- 69 vs
140 +/- 44 mL P < 0.05), and mitral regurgitation were reduced (P < 0.05),
and diastolic filling time was lengthened (P < 0.05). There were also impro
vements in heart failure symptoms, an increase in 6-minute walk distance, a
nd a decrease in QOL scores. Synchronous biventricular pacing for 3 months
was associated with hemodynamic improvements, reversal of left ventricular
remodeling, and increase in left ventricular systolic function, and a decre
ase in secondary mitral regurgitation.